Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

被引：6
|
作者：
McCarthy, Niamh [2 ]
McCarron, Sarah L. [1 ]
Langabeer, Stephen E. [1 ]
机构：
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
ACTA HAEMATOLOGICA | 2010年 / 124卷 / 03期
关键词：
CHRONIC MYELOPROLIFERATIVE DISORDERS; BUDD-CHIARI-SYNDROME; NEOPLASMS; DIAGNOSIS; JAK2V617F;
D O I：
10.1159/000320171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：160 / 161
页数：2
相关论文
共 50 条
  • [41] Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
    Benati, Marco
    Montagnana, Martina
    Danese, Elisa
    De Matteis, Giovanna
    Veneri, Dino
    Paviati, Elisa
    Guidi, Gian Cesare
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1005 - 1011
  • [42] Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?
    Lamy, Matthias
    Palazzo, Paola
    Agius, Pierre
    Chomel, Jean Claude
    Ciron, Jonathan
    Berthomet, Aline
    Cantagrel, Paul
    Prigent, Julia
    Ingrand, Pierre
    Puyade, Mathieu
    Neau, Jean-Philippe
    CEREBROVASCULAR DISEASES, 2017, 44 (3-4) : 97 - 104
  • [43] High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
    Castelli, Roberto
    Gallipoli, Paolo
    Schiavon, Riccardo
    Teatini, Thomas
    Deliliers, Giorgio Lambertenghi
    Bergamaschini, Luigi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 106 - 113
  • [44] Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients
    Besses, Carlos
    Alvarez-Larran, Alberto
    Martinez-Aviles, Luz
    Mojal, Sergi
    Longaron, Raquel
    Salar, Antonio
    Florensa, Lourdes
    Serrano, Sergi
    Bellosillo, Beatriz
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (04) : 413 - 419
  • [45] JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients
    Wang, Hui
    Sun, Guixiang
    Zhang, Peijin
    Zhang, Jing
    Gui, Er
    Zu, Maoheng
    Jia, Enzhi
    Xu, Hao
    Xu, Lichun
    Zhang, Jinpeng
    Lu, Zhaojun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 208 - 214
  • [46] A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F
    Acharya, A.
    Vaniawala, S.
    Parekh, H.
    Sheikh, H.
    Patel, H.
    Ali, R.
    Khan, A.
    Nagee, A.
    Kunjadia, P.
    Mukhopadhyaya, P. N.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (04) : E30 - E33
  • [47] Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
    Kim, Hye-Ran
    Choi, Hyun-Jung
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    PLOS ONE, 2013, 8 (01):
  • [48] Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myetoproliferative disorders with JAK2 V617F
    Gibson, Sarah E.
    Schade, Andrew E.
    Szpurka, Hadrian
    Bak, Beata
    Maciejewski, Jaroslaw P.
    Hsi, Eric D.
    HUMAN PATHOLOGY, 2008, 39 (07) : 1111 - 1114
  • [49] Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosis
    Karakose, Suleyman
    Oruc, Nevin
    Zengin, Melia
    Akarca, Ulus Salih
    Ersoz, Galip
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (01) : 42 - 48
  • [50] Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory
    Merker, Jason D.
    Jones, Carol D.
    Oh, Stephen T.
    Schrijver, Iris
    Gotlib, Jason
    Zehnder, James L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (01) : 58 - 64
12345